Sangrix Inc. (SGRX) stock
SGRXNasdaqFinance ServicesFiscal year ends June 30
$2.56−0.21 (-7.58%)
Close on Nov 17, 2026Market cap $1.91MP/E –Yield –
Sangrix price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Sangrix's price to sales ratio was 5.4× on Aug 31, 2026, against 0.5× a year earlier. Over the last 5 years it ranged from 0.2× to 401.6×, with a median of 2.5×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Aug 31, 2026 | 5.4× | −248.1 |
| 2025 | Dec 31, 2025 | 253.5× | +250.8 |
| 2024 | Dec 31, 2024 | 2.6× | +0.4 |
| 2023 | Dec 29, 2023 | 2.2× | −0.3 |
| 2022 | Dec 30, 2022 | 2.6× | +1.9 |
| 2021 | Dec 31, 2021 | 0.7× | −0.2 |
| 2020 | Dec 31, 2020 | 0.9× | +0.1 |
| 2019 | Dec 31, 2019 | 0.9× | – |
See a number that looks wrong?